Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
David Magnuson, MD, is Chairman of the Department of Pediatric Surgery at Cleveland Clinic. His surgical interests involve the application of innovative minimally invasive technologies to the surgery of infants and children.
He was born and raised in Minnesota. He graduated Magna cum laude from Princeton University in 1979 with a degree in molecular and cell biology. He received his M.D. from the University of Minnesota in 1984, having been elected to the Alpha Omega Alpha medical honor society as a junior.
Dr. Magnuson received all of his surgical training at the University of Washington in Seattle, including a residency in general surgery, an NIH-funded trauma research fellowship and a fellowship in Pediatric Surgery. During his trauma research fellowship, he won the American College of Surgeons National Research Competition in basic science research for his work on molecular mechanisms of septic shock in surgical patients.
From 1993 to 1998 he was on staff at the National Children's Medical Center in Washington, D.C. He first came to the Cleveland Clinic in 1998 in the Department of Pediatric Surgery and started the Pediatric Minimally Invasive Surgery Program there. From 2001 to 2006 he was the Section Head of Pediatric Surgery at Rainbow Babies and Children's Hospital in Cleveland.
In 2007, he returned to the Cleveland Clinic as Chairman of the Department of Pediatric Surgery. Dave and his wife Heidi have been married for 28 years and have four children. They live in Chagrin Falls.
Specialty Interests
congenital malformations, hernia, minimally invasive repair of pectus excavatum/Nuss procedure, Minimally Invasive Surgery, neonatal surgery, pediatric critical care, pediatric general and thoracic surgery, pediatric general surgery and thoracic surgery, pediatric solid tumors, pediatric surgical oncology, pediatric trauma, pediatric tumors
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/21/2013, Dr. Magnuson has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.